Logo Image
News
All NewsDosing & Delivery InnovationsPress ReleasesProduct Approvals and Launches
Watch
Expert ConversationsNews & AnalysisShows & Podcasts
Journals
All JournalsThe American Journal of Managed CarePopulation Health, Equity & OutcomesEvidence-Based OncologyAbout Supplements and Featured PublicationsSupplements and Featured Publications IssuesSubmit a Manuscript
Conferences
Conference CoverageConference ListingPost Conference Perspectives
More
Events
AJMC EventsEvents CalendarInstitute for Value-Based MedicinePatient-Centered Oncology CarePopulation Health RoundtablesWebinars
Resources
Interactive ToolsFormulary CentralClinical SpotlightMicrositesSponsored Content
CE
About AJMC
AJMC StaffAnniversarySeema Sonnad AwardStrategic Alliance Partners

Subscribe

  • News
  • Watch
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
  • Biosimilars
  • Cardiorenalmetabolic
    • Cardiomyopathy
    • Cardiovascular
    • Chronic Kidney Disease
    • Diabetes
    • Heart Failure
    • Type 1 Diabetes
  • Dermatology
    • Alopecia
    • Atopic Dermatitis
    • Chronic Hand Eczema
    • Psoriasis
  • Gastroenterology
  • Hematology
    • ALL/AML
    • CLL/SLL
    • GVHD
    • Hemophilia
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Non-Hodgkin Lymphoma
    • Rare Blood
  • Hepatology
    • Hepatitis
    • Liver
    • MASH
  • Immunology
    • Allergy
    • Autoimmune
    • Inflammation
    • Lupus
    • Myasthenia Gravis
    • Rheumatoid Arthritis
  • Infectious Disease
    • COVID-19
    • HIV
    • RSV
    • Vaccines
  • Mental Health
    • Major Depressive Disorder
    • Sleep
  • Neurology
    • Duchenne Muscular Dystrophy
    • Epilepsy
    • Multiple Sclerosis
    • Parkinson Disease
  • Obesity
  • Oncology
    • Breast Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Immuno-Oncology
    • Liver Cancer
    • Non–Small Cell Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Small Cell Lung Cancer
    • Soft Tissue Sarcoma
  • Ophthalmology
  • Pulmonology
    • COPD
    • Pulmonary Arterial Hypertension
  • Rare Disease
    • Spinal Muscular Atrophy
  • Respiratory
    • Asthma
    • Pulmonary Fibrosis
  • Rheumatology
  • Urology
    • Overactive Bladder
  • Women's Health
    • Endometriosis
  • Biosimilars
  • Bispecifics Network
  • Center on Health Equity & Access
  • Digital Health
  • Dosing & Delivery Innovations
  • Formulary
  • Gene Therapy
  • Guidelines
  • Health Care Administration
    • Employers
    • Medicare
    • Reimbursement
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Population Health
  • Product Approvals and Launches
  • Technology
  • Value-Based Care
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement
|Articles|December 4, 2020

Lurbinectedin: NCCN Guidelines

Advertisement

Advertisement
Guidelines

Related Content

Advertisement
Keith Bellovich, Do, MBA

CKM Guideline Aims to Break Down Specialty Silos: Keith Bellovich, DO

ByGiuliana Grossi,Keith Bellovich, DO, MBA
September 3rd 2026
Cervical Cancer-art4stock-stock.adobe.com.jpeg

Never-Screened Cervical Cancer Rates Climb Among US Women

ByGiuliana Grossi
August 27th 2026
Weight loss injections. | Image Credit:  ricka_kinamoto - stock.adobe.com

ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity

ByGiuliana Grossi
June 15th 2026
FDA approval | Image Credit: Tada Images  - stock.adobe.com .jpeg

5 Key Regulatory Shifts From Makary's Era at the FDA

ByPearl Steinzor
May 13th 2026
Marking 10 years since the CDC’s opioid prescribing guidelines, the 2022 update broadens patient care, emphasizes individualized decisions, and aims to reduce opioid-related harms. | Imaged credit: Tada Images - stock.adobe.com

The 10th Anniversary of the CDC's Opioid Prescribing Guidelines: New Evidence and Patient-Centered Decisions

BySabrina McCrear
March 24th 2026
Advertisement
Advertisement

Trending on AJMC

1

Tozorakimab Cuts COPD Exacerbations Up to 34% in Phase 3 Trials

2

The True Cost of Running a Community CAR T-Cell Program

3

Bringing CAR T-Cell Therapy Into Community Cancer Centers

4

Trump Admin Awards $106M to Expand Rural Health Care in NY, RI, MI

5

FDA Approves First Disease-Modifying Treatment for AxD

Brand Logo
  • About
  • Contact
  • Editorial Boards
  • Advertise
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2026 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text